SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Chronic kidney disease (CKD) is a major public health issue affecting an estimated 850 million people globally. The leading causes of CKD is diabetes and hypertension, which together account for >50% of patients with end-stage kidney disease. Progressive CKD leads to the requirement for kidney re...

Descripción completa

Detalles Bibliográficos
Autores principales: Mark, Patrick B, Sarafidis, Pantelis, Ekart, Robert, Ferro, Charles J, Balafa, Olga, Fernandez-Fernandez, Beatriz, Herrington, William G, Rossignol, Patrick, Del Vecchio, Lucia, Valdivielso, Jose M, Mallamaci, Francesca, Ortiz, Alberto, Nistor, Ionut, Cozzolino, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615631/
https://www.ncbi.nlm.nih.gov/pubmed/37230946
http://dx.doi.org/10.1093/ndt/gfad112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615631/
https://www.ncbi.nlm.nih.gov/pubmed/37230946
http://dx.doi.org/10.1093/ndt/gfad112

Ejemplares similares